American Century Companies Inc Sigilon Therapeutics, Inc. Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$2.58 - $6.13 $927,995 - $2.2 Million	-359,688 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$4.42 - $10.61 $153,842 - $369,291	34,806 Added 10.71%	359,688 $2.03 Million
Q2 2021 Aug 05, 2021	BUY	$9.15 - $20.17 $1.21 Million - $2.68 Million	132,706 Added 69.05%	324,882 $3.49 Million
Q1 2021 May 14, 2021	BUY	$18.76 - $40.91 $893,069 - $1.95 Million	47,605 Added 32.93%	192,176 $4.3 Million
Q4 2020 Feb 12, 2021	BUY	$27.6 - $48.03 $3.99 Million - $6.94 Million	144,571 New	144,571 $6.94 Million

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.